Literature DB >> 27408249

Adrenaline, Noradrenaline and Dopamine Level Estimation in Depression : Does it Help?

V Ambade1, M M Arora2, P Singh3, B L Somani4, D Basannar5.   

Abstract

BACKGROUND: Abnormalities of catecholaminergic function have been hypothesised in causation of depressive illness. Electroconvulsive therapy (ECT) is postulated to have noradrenergic mechanism of action. We studied the clinical utility of estimating catecholamines level changes after ECT.
METHODS: Plasma adrenaline, noradrenaline and dopamine in healthy controls and depressed patients were estimated by high performance liquid chromatography with electrochemical detection method before and after ECT. RESULT: Mean ± standard deviation of plasma adrenaline, noradrenaline and dopamine in controls was 36.7 ± 13.2, 209.3 ± 76, 21.8 ± 9.5 ng/L respectively, while in depressed patients before and after ECT it was found to be 32.5 ± 12.0, 419.3 ± 167.7, 22.1 ± 16.0ng/ L and 37.2 ± 19.6, 386.1 ± 168.4, 22.3 ± 15.5ng/L respectively. Correlation of adrenaline, noradrenaline and dopamine concentration with scores of Beck Depression Inventory, Suicidal Ideation Scale and Melancholia Inventory was positive but statistically not significant and poor. Based on the cut off values of noradrenaline, only 62% cases could be categorized as abnormal, which after ECT reduced to 50%, whereas post ECT psychiatric ratings was normal in about 78% cases.
CONCLUSION: There is no clinical significance of estimating adrenaline, noradrenaline and dopamine in depressed patients.

Entities:  

Keywords:  Adrenaline; Dopamine; Electroconvulsive therapy; Noradrenaline; Psychiatric scales

Year:  2011        PMID: 27408249      PMCID: PMC4921403          DOI: 10.1016/S0377-1237(09)80006-3

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  20 in total

1.  Single and repeated electroconvulsive shocks activate dopaminergic and 5-hydroxytryptaminergic neurotransmission in the frontal cortex of rats.

Authors:  K Yoshida; H Higuchi; M Kamata; M Yoshimoto; T Shimizu; Y Hishikawa
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1998-02       Impact factor: 5.067

2.  Dopamine releasing response in rat striatum to single and repeated electroconvulsive shock treatment.

Authors:  K Yoshida; H Higuchi; M Kamata; M Yoshimoto; T Shimizu; Y Hishikawa
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1997-05       Impact factor: 5.067

3.  Effects of electroconvulsive therapy on peripheral adrenoceptors, plasma, noradrenaline, MHPG and cortisol in depressed patients.

Authors:  E S Werstiuk; M Coote; L Griffith; H Shannon; M Steiner
Journal:  Br J Psychiatry       Date:  1996-12       Impact factor: 9.319

4.  Plasma noradrenaline response to electroconvulsive therapy in depressive illness.

Authors:  C B Kelly; S J Cooper
Journal:  Br J Psychiatry       Date:  1997-08       Impact factor: 9.319

Review 5.  [Biochemical diagnosis of pheochromocytoma and neuroblastomas].

Authors:  M Candito; E Billaud; M Chauffert; J M Cottet-Emard; D Desmoulin; J P Garnier; J Greffe; C Hirth; N Jacob; F Millot; A Nignan; M C Patricot; L Peyrin; P F Plouin
Journal:  Ann Biol Clin (Paris)       Date:  2002 Jan-Feb       Impact factor: 0.459

6.  High plasma norepinephrine levels in patients with major affective disorder.

Authors:  C R Lake; D Pickar; M G Ziegler; S Lipper; S Slater; D L Murphy
Journal:  Am J Psychiatry       Date:  1982-10       Impact factor: 18.112

Review 7.  [Treatment strategy of refractory depression and its presynaptic mechanism of action].

Authors:  Takeshi Inoue; Yuji Kitaichi; Tsukasa Koyama
Journal:  Nihon Shinkei Seishin Yakurigaku Zasshi       Date:  2003-02

Review 8.  Measurement of catecholamines and their metabolites.

Authors:  Robert T Peaston; Cyril Weinkove
Journal:  Ann Clin Biochem       Date:  2004-01       Impact factor: 2.057

9.  The effect of temperature on the analysis of metanephrine for catechol-O-methyltransferase activity assay by HPLC with electrochemical detection.

Authors:  L A Passarinha; M J Bonifácio; J A Queiroz
Journal:  Biomed Chromatogr       Date:  2006-09       Impact factor: 1.902

10.  Adrenergic receptors in depression. Effects of electroconvulsive therapy.

Authors:  S J Cooper; J G Kelly; D J King
Journal:  Br J Psychiatry       Date:  1985-07       Impact factor: 9.319

View more
  6 in total

Review 1.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

2.  Vegetated land cover near residence is associated with reduced allostatic load and improved biomarkers of neuroendocrine, metabolic and immune functions.

Authors:  Andrey I Egorov; Shannon M Griffin; Reagan R Converse; Jennifer N Styles; Elizabeth A Sams; Anthony Wilson; Laura E Jackson; Timothy J Wade
Journal:  Environ Res       Date:  2017-07-11       Impact factor: 6.498

3.  Evaluation of Endocrine Parameters as Predictor of Major Depressive Disorder.

Authors:  Soma Gupta; Amrita Mukherjee; Sangita Biswas; Smarajit Bose; Saswati Nath; Harendra Nath Das
Journal:  Indian J Psychol Med       Date:  2017 Nov-Dec

4.  Dopamine levels in human tear fluid.

Authors:  Niyati Seshagiri Sharma; Suraj Kumar Acharya; Archana Padmanabhan Nair; Jyoti Matalia; Rohit Shetty; Arkasubhra Ghosh; Swaminathan Sethu
Journal:  Indian J Ophthalmol       Date:  2019-01       Impact factor: 1.848

5.  A Systematic Review of Neuromodulation Treatment Effects on Suicidality.

Authors:  Mehmet Utku Kucuker; Ammar G Almorsy; Ayse Irem Sonmez; Anna N Ligezka; Deniz Doruk Camsari; Charles P Lewis; Paul E Croarkin
Journal:  Front Hum Neurosci       Date:  2021-06-25       Impact factor: 3.169

6.  Dopaminergic effects on in vitro osteogenesis.

Authors:  Dong Joon Lee; Henry C Tseng; Sing Wai Wong; Zhengyan Wang; Meng Deng; Ching-Chang Ko
Journal:  Bone Res       Date:  2015-07-07       Impact factor: 13.567

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.